Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-09 5:00 pm Purchase |
2022-06-24 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 4,220,397 9.200% |
1,972,873 (+87.78%) |
Filing History |
| 2022-06-10 11:04 am Sale |
2022-06-09 | 13G | BioAtla, Inc. BCAB |
FMR CORP | 315,211 0.877% |
-3,605,461 (-91.96%) |
Filing History |
| 2022-04-28 4:00 pm Purchase |
2022-04-18 | 13G | BioAtla, Inc. BCAB |
TANG CAPITAL PARTNERS LP | 2,288,900 6.400% |
2,288,900 (New Position) |
Filing History |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | BioAtla, Inc. BCAB |
SHORT JAY M PHD | 2,701,327 7.540% |
2,701,327 (New Position) |
Filing History |
| 2022-02-14 3:07 pm Sale |
2021-12-31 | 13G | BioAtla, Inc. BCAB |
Cormorant Asset Management LP | 2,038,215 5.770% |
-253,845 (-11.07%) |
Filing History |
| 2022-02-11 4:55 pm Sale |
2021-12-31 | 13G | BioAtla, Inc. BCAB |
PFIZER INC PFE |
1,372,052 3.880% |
-866,038 (-38.70%) |
Filing History |
| 2022-02-11 4:04 pm Sale |
2021-12-31 | 13G | BioAtla, Inc. BCAB |
HBM BIOVENTURES CAYMAN LTD | 1,427,317 4.000% |
-1,263,552 (-46.96%) |
Filing History |
| 2022-02-09 3:33 pm Purchase |
2021-12-31 | 13G | BioAtla, Inc. BCAB |
The Vanguard Group | 2,264,654 6.410% |
2,264,654 (New Position) |
Filing History |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | BioAtla, Inc. BCAB |
FMR CORP | 3,920,672 11.092% |
-156,919 (-3.85%) |
Filing History |
| 2022-02-08 11:52 am Unchanged |
2021-12-31 | 13G | BioAtla, Inc. BCAB |
FARALLON CAPITAL MANAGEMENT LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-04 09:15 am Purchase |
2021-12-31 | 13G | BioAtla, Inc. BCAB |
WELLINGTON MANAGEMENT CO LLP | 3,232,480 9.150% |
3,232,480 (New Position) |
Filing History |
| 2021-09-03 5:16 pm Sale |
2021-08-24 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 2,247,524 6.950% |
-546,709 (-19.57%) |
Filing History |
| 2021-06-28 4:32 pm Sale |
2021-06-17 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 2,794,233 8.690% |
-400,000 (-12.52%) |
Filing History |
| 2021-04-12 1:05 pm Purchase |
2021-04-09 | 13G | BioAtla, Inc. BCAB |
FMR CORP | 4,077,591 12.674% |
2,297,505 (+129.07%) |
Filing History |
| 2021-02-16 4:19 pm Purchase |
2021-02-16 | 13G | BioAtla, Inc. BCAB |
Himalaya Parent LLC | 8,682,304 26.990% |
8,682,304 (New Position) |
Filing History |
| 2021-02-16 3:16 pm Unchanged |
2020-12-31 | 13G | BioAtla, Inc. BCAB |
Cormorant Asset Management LP | 2,292,060 7.120% |
0 (Unchanged) |
Filing History |
| 2021-02-12 6:00 pm Purchase |
2020-12-31 | 13G | BioAtla, Inc. BCAB |
PFIZER INC PFE |
2,238,090 7.000% |
2,238,090 (New Position) |
Filing History |
| 2021-02-08 10:17 am Purchase |
2021-02-05 | 13G | BioAtla, Inc. BCAB |
FMR CORP | 1,780,086 5.533% |
1,780,086 (New Position) |
Filing History |
| 2020-12-28 4:30 pm Purchase |
2020-12-15 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 3,194,233 9.930% |
3,194,233 (New Position) |
Filing History |
| 2020-12-28 4:06 pm Purchase |
2020-12-15 | 13G | BioAtla, Inc. BCAB |
HBM BIOVENTURES CAYMAN LTD | 2,690,869 8.800% |
2,690,869 (New Position) |
Filing History |